Cancer News and Research

Latest Cancer News and Research

Novartis applauds declaration of CML Awareness Day in Canada

Today is a meaningful milestone for chronic myelogenous leukemia (CML) patients and their families.

23 Sep 2010

Texas grapples with medical malpractice reform while Illinois addresses employer health care costs

Texas Tribune: "As a federal judge considers the constitutionality of Texas' 2003 medical malpractice reform — and Gov. Rick Perry campaigns for more lawsuit restrictions — the Texas Supreme Court has narrowly ruled that hospital injuries seemingly unrelated to doctor error can still fall under the state's stringent medical malpractice caps.

23 Sep 2010

NCI selects Caliper's Quantum FX microCT system to study tumor models in lung cancer

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that the National Cancer Institute has purchased Caliper's Quantum FX, a stand-alone microCT system for pre-clinical imaging, to study spontaneous tumor models in lung cancer.

23 Sep 2010

University of Illinois at Chicago receives $12.4M grant to study smoking behaviors in young adults

The University of Illinois at Chicago has received a $12.4 million grant from the National Cancer Institute to study the predictors of smoking patterns from adolescence through young adulthood.

23 Sep 2010

Revolutionary technology 'cooks' brain tumor

University Hospitals (UH) Case Medical Center is offering new hope for patients with inoperable brain tumors or lesions previously diagnosed as untreatable through a revolutionary technology called AutoLITT which "cooks" brain tumors with an MRI-guided laser. UH becomes one of only three medical centers in the world offering AutoLITT as part of its arsenal in the fight against cancer. It is especially effective in treating glioblastoma, one of the most aggressive and difficult-to-treat brain cancers.

23 Sep 2010

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted regulatory submissions for review of the investigational drug vandetanib in the treatment of patients with advanced medullary thyroid cancer (MTC). The FDA also granted priority review status for the new drug application and set a Prescription Drug User Fee Act (PDUFA) action date of 7 January 2011.

23 Sep 2010

Signal Genetics, Array BioPharma partner to advance personalized medicine in multiple myeloma

Signal Genetics, a privately held predictive genetic testing company focused on oncology, today announced the company will work with Array BioPharma to help push forward both companies' goals of markers for patient selection, helping bring personalized medicine and companion diagnostics to patients with multiple myeloma, a cancer of the bone marrow and antibody producing cells.

23 Sep 2010

FDA approves Roche's COBAS AmpliPrep / COBAS TaqMan HBV Test v2.0

Roche Molecular Diagnostics announced today that the U.S. Food & Drug Administration (FDA) has approved the COBAS® AmpliPrep / COBAS® TaqMan® HBV Test v2.0 for use in the United States. The new Roche test provides a fully automated solution for the quantitative detection of hepatitis B virus (HBV) DNA in human plasma or serum for patients on HBV antiviral therapy.

23 Sep 2010

Mitsui Ventures invests US$5 million to support S*BIO's clinical program

S*BIO Pte Ltd today announced a US$5 million investment by Mitsui Ventures that will support the continued development of S*BIO's clinical programs.

23 Sep 2010

High selenium intake associated with lower rates of bladder cancer in women

Scientists in Spain have found that adding a can of tuna or other fish to our shopping lists could help protect us against bladder cancer.

23 Sep 2010

Masonic Cancer Center receives five-year program project research grants from NCI

Two of the University of Minnesota Masonic Cancer Center's leading physician-scientists on research and treatment of cancers of the blood and bone marrow Philip McGlave, M.D., and Jeffrey Miller, M.D., have received renewed five-year program project research grants totaling almost $26 million from the National Cancer Institute (NCI).

23 Sep 2010

DCGI approves ADXS11-001 human testing for cervix cancer

As part of approving the human testing of ADXS11-001 the lead agent for the treatment of cervix cancer of Advaxis, Inc., the live, attenuated Listeria monocytogenes (Listeria) immunotherapy company the Drugs Controller General of India (DCGI) required that the agent be tested to assure its safety prior to use.

23 Sep 2010

Women face sexual function problems after breast cancer

A new study published in the Journal of Sexual Medicine looked at whether women were more likely to experience sexual problems after breast cancer. The results showed that 70% of women were facing sexual function problems approximately two years post diagnosis.

23 Sep 2010

Male partners of women with breast cancer at increased risk of developing mood disorders

A new analysis finds that men whose partners have breast cancer are at increased risk of developing mood disorders that are so severe that they warrant hospitalization. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that clinicians should address the mental health of cancer patients' loved ones.

23 Sep 2010

Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress

Infinity Pharmaceuticals, Inc. today announced that Phase 1 data of its novel Hedgehog pathway inhibitor, IPI-926, will be presented during the 35th Congress of the European Society of Molecular Oncology (ESMO), in Milan, Italy.

23 Sep 2010

Mother’s miracle surgery for cancer - body cut in half

Janis Ollson, 31 became the first patient to survive a rare bone cancer which required her body to be cut in half. When she was pregnant with her second child doctors assumed her intense back pain was just a typical symptom of pregnancy. But soon she was diagnosed with a bone cancer called sarcoma that was untreatable by chemotherapy or radiation.

23 Sep 2010

Anthera Pharmaceuticals closes financing transaction

Anthera Pharmaceuticals, Inc., today announced that it has entered into definitive agreements with certain accredited investors in connection with a private placement, or PIPE, financing transaction pursuant to Section 4(2) of the Securities Act of 1933, as amended, and Regulation D promulgated thereunder.

23 Sep 2010

Kim Hames says case was not euthanasia

Western Australia has been debating euthanasia for a while and in a new development, Health Minister and Deputy Premier Kim Hames has admitted that as a GP he administered the painkiller morphine to hasten a cancer patient's death. He said in his statement that what he had done was legal and not euthanasia – which he opposed. His reasoning was that the pain relieving medication was intended to ease a patient's suffering rather than end their life.

23 Sep 2010

GATC Biotech to purchase PacBio real-time sequencing technology

GATC Biotech announced today that it has agreed to purchase the PacBio RS platform, a single molecule, real-time (SMRT™) sequencing technology. The new PacBio RS will be the fifth sequencing technology for GATC Biotech. The system is planned for installation in early 2011.

22 Sep 2010

Scientists develop new therapy for treatment of skin, lung cancer

Scientists at the University of Granada have developed a new therapy for the treatment of skin and lung cancer. This therapy involves the use of a suicide coliphage-gene (gene E) that can induce death to cells transfected with it.. Their studies have demostrated that this technique is not only effective in vitro (using tumour cell cultures), but also in vivo through the use of experimental animals in which tumours were induced.

22 Sep 2010

Cancer News and Research

Latest Cancer News and Research

Novartis applauds declaration of CML Awareness Day in Canada

Texas grapples with medical malpractice reform while Illinois addresses employer health care costs

NCI selects Caliper's Quantum FX microCT system to study tumor models in lung cancer

University of Illinois at Chicago receives $12.4M grant to study smoking behaviors in young adults

Revolutionary technology 'cooks' brain tumor

FDA and EMA accept regulatory submissions of vandetanib for advanced medullary thyroid cancer

Signal Genetics, Array BioPharma partner to advance personalized medicine in multiple myeloma

FDA approves Roche's COBAS AmpliPrep / COBAS TaqMan HBV Test v2.0

Mitsui Ventures invests US$5 million to support S*BIO's clinical program

High selenium intake associated with lower rates of bladder cancer in women

Masonic Cancer Center receives five-year program project research grants from NCI

DCGI approves ADXS11-001 human testing for cervix cancer

Women face sexual function problems after breast cancer

Male partners of women with breast cancer at increased risk of developing mood disorders

Infinity Pharmaceuticals to present IPI-926 inhibitor Phase 1 data at ESMO Congress

Mother’s miracle surgery for cancer - body cut in half

Anthera Pharmaceuticals closes financing transaction

Kim Hames says case was not euthanasia

GATC Biotech to purchase PacBio real-time sequencing technology

Scientists develop new therapy for treatment of skin, lung cancer

Industry Focus: Cell & Gene Therapy eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Cancer News and Research

Latest Cancer News and Research

Industry Focus: Cell & Gene Therapy eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in